M. Márquez

发表

HIV infection in the era of highly active antiretroviral therapy: the Malaga Study

J. De La Torre, Jesús Santos, R. Palacios, 2004, International journal of STD & AIDS.

Gynaecomastia in HIV-Infected Men on Highly Active Antiretroviral Therapy: Association with Efavirenz and Didanosine Treatment

J. Macías, J. Pineda, A. Fernández-Palacín, 2004, Antiviral therapy.

Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus

J. Torre-Cisneros, A. Vergara, P. Viciana, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus–coinfected patients with mild fibrosis in the short term

J. Macías, J. Pineda, Á. Camacho, 2015, Hepatology.

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain

A. Rivero‐Juárez, A. Rivero, L. López-Cortés, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Whole blood platelet aggregometry in HIV-infected patients on treatment with abacavir *

J. González-Correa, J. P. Cruz, Jesús Santos, 2012 .

Study of patients diagnosed with advanced HIV in the HAART era – OMEGA Cohort

R. Palacios, M. Márquez, J. Santos, 2005, International journal of STD & AIDS.

High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B.

C. Martín, A. Esteve, S. Samper, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of and Risk Factors for Insulin Resistance in Treatment-Naive HIV-Infected Patients 48 Weeks after Starting Highly Active Antiretroviral Therapy

J. Macías, J. Pineda, J. Gómez-Mateos, 2005, Antiviral therapy.

Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.

J. Macías, J. Pineda, A. Rivero‐Juárez, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus–coinfected patients

J. Macías, J. Pineda, A. Rivero, 2012, Hepatology.

Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patients.

J. Olalla, J. Colmenero, R. Palacios, 2010, AIDS research and human retroviruses.

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

S. Mauss, S. Scholten, J. Fehr, 2015, PloS one.

In vitro susceptibilities of bloodstream isolates of Candida spp.: results from a multicenter active surveillance program in Andalusia.

J. Cisneros, M. Herrero, C. Flórez, 2009, Enfermedades infecciosas y microbiologia clinica.

Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.

J. Zamora, J. Navarro, M. Crespo, 2017, Enfermedades infecciosas y microbiologia clinica.

Efficacy and safety of once‐daily maraviroc plus ritonavir‐boosted darunavir in pretreated HIV‐infected patients in a real‐life setting

J. Macías, M. Márquez, N. Chueca, 2014, HIV medicine.

[Immunopathogenic aspects of infection by the human immunodeficiency virus in Venezuela].

I. Blanca, M. Márquez, N. Bianco, 1988, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.

Short-term lipid changes associated with highly active antiretroviral therapy in naive HIV-infected patients.

Jesús Santos, R. Palacios, M. Márquez, 2003, Journal of acquired immune deficiency syndromes.

Factors associated with the development of diabetes mellitus in HIV-infected patients on antiretroviral therapy: a case-control study.

Jesús Santos, R. Palacios, M. Márquez, 2003, AIDS.

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.

J. Macías, J. Pineda, A. Rivero, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cardiac tamponade caused by Nocardia asteroides in an HIV-infected patient.

A. Esteve, M. Márquez, J. Santos, 2000, The Journal of infection.

Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study).

Jesús Santos, R. Palacios, M. Márquez, 2005, International journal of STD & AIDS.

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

J. Losa, J. Bisbe, S. Reus, 2018, Open forum infectious diseases.

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

M. Crespo, A. Rivero, M. Vivancos, 2016, Open forum infectious diseases.

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

J. Macías, J. Pineda, A. Rivero, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liver stiffness correlates with Child‐Pugh‐Turcotte and MELD scores in HIV/hepatitis C virus‐coinfected patients with cirrhosis

J. Macías, J. Pineda, A. Rivero, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

R. López-Vélez, S. Videla, J. Alvar, 2004, The Journal of antimicrobial chemotherapy.

A randomized study investigating the efficacy and safety of amprenavir in combination with low‐dose ritonavir in protease inhibitor‐experienced HIV‐infected adults

C. Katlama, N. Clumeck, F. Pulido, 2004, HIV medicine.

Once-daily antiretroviral therapy: Spanish Consensus Statement.

D. Podzamczer, J. Mallolas, J. Ena, 2005, The Journal of antimicrobial chemotherapy.

Low Incidence of Severe Liver Events in HIV Patients With and Without Hepatitis C or B Coinfection Receiving Lopinavir/Ritonavir

J. Torre-Cisneros, J. Macías, J. Pineda, 2006, HIV clinical trials.

T cell receptor excision circles (TRECs), CD4+, CD8+ and their CD45RO+ and CD45RA+ subpopulations in hepatitis C virus (HCV)‐HIV‐co‐infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy

M. Márquez, J. Girón-González, C. Fernández-Gutiérrez, 2006, Clinical and experimental immunology.

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients

J. Macías, J. Pineda, A. Rivero, 2012, AIDS.

Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy

J. Macías, J. Pineda, Á. Camacho, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Impact of highly active antiretroviral therapy on blood pressure in HIV‐infected patients. A prospective study in a cohort of naive patients

E. Castells, R. Palacios, M. Márquez, 2006, HIV medicine.

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients

J. Macías, M. Márquez, E. Ortega, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Lung cancer in HIV-infected patients

A. Del Arco, J. Colmenero, R. Palacios, 2012, International journal of STD & AIDS.

Unusual malignant tumours in patients with HIV infection

R. Palacios, M. Márquez, J. Santos, 2002, International journal of STD & AIDS.

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients

C. Tural, J. Macías, J. Pineda, 2013, AIDS.

Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature

R. Palacios, M. Márquez, P. Valdivielso, 2002, Lupus.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

J. Mallolas, E. Ribera, M. Márquez, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C.

J. Macías, J. Pineda, A. Rivero, 2011, Journal of Antimicrobial Chemotherapy.

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

J. Macías, J. Pineda, A. Rivero, 2008, The Journal of antimicrobial chemotherapy.

Impact of Acute Hepatitis A Virus (HAV) Infection on HIV Viral Load in HIV-Infected Patients and Influence of HIV Infection on Acute HAV Infection

R. Palacios, E. Nuño, M. Márquez, 2011, Journal of the International Association of Physicians in AIDS Care.

Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity

Jesús Santos, R. Palacios, E. Nuño, 2015, International journal of STD & AIDS.

Rapid Communications: Failure of a Short‐Term Prednisone Regimen to Prevent Nevirapine‐Associated Rash: A Double‐Blind Placebo‐Controlled Trial: The GESIDA 09/99 Study

J. Miro, J. Blanco, A. Rivero, 2001, Journal of acquired immune deficiency syndromes.

Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy.

Rosario Palacios, Jesús Santos, Mercedes González, 2002, Journal of acquired immune deficiency syndromes.

Impact of IL28B Genotype on First-Week Response to Telaprevir-Based Therapy in HIV–HCV Coinfection

J. Rockstroh, S. Scholten, A. Rauch, 2014, Antiviral therapy.

Red Cell Distribution Width in Patients with HIV Infection

Jesús Santos, R. Palacios, E. Nuño, 2012 .

J. Macías, J. Pineda, Á. Camacho, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Effect of antiretroviral therapy on admissions of HIV‐infected patients to an intensive care unit

R. Palacios, M. Márquez, A. Hidalgo, 2006, HIV medicine.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

J. Rodríguez-Baño, J. Macías, J. Pineda, 2009, Gut.

A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.

J. Pineda, Á. Camacho, A. Rivero, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: Prospective analysis at 48 weeks of highly active antiretroviral therapy

Jesús Santos, R. Palacios, M. Márquez, 2007, International journal of STD & AIDS.

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain

A. Rivero, L. López-Cortés, M. Márquez, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir.

J. Torre-Cisneros, J. Pineda, A. Rivero, 2006, The Journal of antimicrobial chemotherapy.

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

R. Palacios, E. Nuño, M. Márquez, 2010, Journal of the International AIDS Society.

[Pneumothorax in patients with AIDS].

Jesús Santos, M. Márquez, Antonio Rivero, 1994, Enfermedades Infecciosas y Microbiologia Clinica.

EFFECTIVENESS OF GLYCYRRHIZINIC ACID AND AN IMMUNOSTIMULANT TO TREAT GENITAL WARTS IN THE PEDIATRIC PATIENT POPULATION

M. Márquez, E. Romo, F. P. Fundora, 2013 .

[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients].

A. Rivero, F. Lozano, M. Márquez, 2007, Enfermedades infecciosas y microbiologia clinica.

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus–coinfected patients with mild fibrosis in the short term

J. Macías, J. Pineda, Á. Camacho, 2015, Hepatology.

Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study.

J. Miro, J. Blanco, A. Rivero, 2001, Journal of acquired immune deficiency syndromes.